BioSyent Releases Results for Q1 2019
May 29, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three months ended March 31, 2019. Key highlights...
BioSyent Schedules Q1 2019 Earnings Release for May 29, 2019
May 21, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2019 on Wednesday,...
BioSyent Announces Health Canada Approval of New Women’s Health Product
May 13, 2019 16:01 ET
|
BioSyent Inc.
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Tibella® (tibolone), indicated for the short-term...
BioSyent Releases Results for Fourth Quarter and Full Year 2018
March 20, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2018. Key...
BioSyent Announces Normal Course Issuer Bid
December 04, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice...
BioSyent Releases Results for Third Quarter and First Nine Months of 2018
November 21, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September 30, 2018. Key...
BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Sixth Consecutive Year
September 13, 2018 09:00 ET
|
BioSyent Inc.
TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the annual Growth 500 ranking of Canada’s Fastest-Growing...
BioSyent Announces Changes to Executive Management
September 10, 2018 17:28 ET
|
BioSyent Inc.
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced changes to its Executive Management team: Effective on September 10, 2018, Mr....
BioSyent to Present at Upcoming Investor Conference
August 24, 2018 12:00 ET
|
BioSyent Inc.
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at...
BioSyent Schedules Q1 2018 Earnings Release for May 30, 2018
May 17, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture:RX) will be reporting its financial results for the first quarter ended March 31, 2018 on Wednesday,...